Background: Bisphenol A (BPA) and phthalates metabolites are linked to a variety of adverse health consequences but studies have not explored their association with growth trajectories.
Introduction
Childhood obesity is globally persistent with multifactorial causes and a wide range of complications that can track into adulthood (1) . Increasingly, evidence suggests that exposures to environmental endocrine-disrupting compounds such as Bisphenol A (BPA) and phthalates may influence body weight and physiology, such as insulin resistance (2) (3) (4) . These multifunctional compounds are used in everyday products leading to ubiquitous exposure (5, 6) . BPA is used in the production of polycarbonate plastics and epoxy resins and is commonly found in food and beverage containers, medical equipment, toys, the linings of canned foods, thermal receipt paper, and dental sealants (7) . Phthalates are used similarly as plasticizers in many consumer and industrialized products and as a stabilizing and solubilizing material (8) . Associations between exposures to these compounds and increased body mass index (BMI) and adiposity differ by sex, population, and age of exposure, but many studies suggest positive associations (9) (10) (11) (12) . However, no longitudinal studies have investigated the role that in utero exposures to these compounds may have on growth trajectories. Assessing whether growth differs by levels of exposure could be used to link childhood trajectories with periods of risk and later adult health like obesity (13) . In this study, we add to our previously reported associations between in utero and childhood urinary concentrations of BPA and phthalates metabolites on childhood BMI and adiposity (12) . We examined BMI growth trajectories of children exposed to these compounds in utero to assess how different levels of exposures may influence growth. An exploratory method of growth modelling was applied to fit and assess the trajectories of BMI for male and female children by tertiles of third trimester BPA and phthalates metabolites.
Methods

Study population
The Early Life in Mexico to ENvironmental Toxicants (ELEMENT; n = 249) is a 22-year long research collaboration with Mexico's Instituto Nacional de Salud Pública (INSP) that consists of three sequentially enrolled birth cohorts from Mexico City serving low-tomoderate income populations, recruited from 1997 to 2005, and described elsewhere (14) . Briefly, women were recruited to ELEMENT to examine the influence of in utero exposures to environmental toxicants on child development and health. Similar exclusions were applied to all three cohorts including living outside of Mexico City, gestational diabetes, preeclampsia, or pregnancy-related hypertensive disorders. Across each of the three cohorts, women were recruited during the first trimester of pregnancy or at delivery. Follow-up of the cohorts were continuously maintained with child measurements collected at each study visit when the children were 3, 6 and 12 months of age and then every 6 months until 60 months. These children were then maintained in follow-up with 1-3 additional observations collected when children were between 8 and 14 years old, collected between 2006 and 2012 and conducted by trained personnel. Maternal education was obtained from the interviewer-administered baseline questionnaire. The research protocols were approved by the Ethics and Research Committees of INSP in Mexico and the Institutional Review Boards at Harvard University and University of Michigan Schools of Public Health, and informed consent and assent of minors were provided by all participants prior to enrollment.
Anthropometric measures
Children's weights and heights were taken by study personnel using established research protocols, in hospital gowns and without shoes (15) . Weight (BAME Mod 420; Catálogo Médico) was measured to the nearest 0.1 kg, and height (BAME Mod 420; Catálogo Médico) was measured to the nearest 0.1 cm. Duplicate measures were taken of heights and weights and, if intrapersonal variability exceeded the measurement tolerance of 0.5 cm, an additional measurement was taken. The observed values were averaged. BMI was calculated as weight divided by height squared (kg/m 2 ).
Urinary Bisphenol A and phthalates metabolites
A spot (second morning void) urine sample from women during their third-trimester visit (average gestational age of 34.06 weeks) was collected in sterile cups, aliquoted an hour after collection, and frozen at À20°C. These samples were then transferred to the project's research center, frozen at À80°C, and shipped to the University of Michigan for storage. Samples were analyzed for total (free + glucuronidated) BPA and nine phthalates metabolites by NSF International (Ann Arbor, MI, USA) using validated modification of the Centers for Disease Control and Prevention methods described elsewhere (16) . The nine phthalates metabolites included monoethyl phthalate (MEP), metabolite of diethyl phthalate; mono-n-butyl phthalate, metabolite of di-n-butyl phthalate; mono-isobutyl phthalate (MiBP), metabolite of di-isobutyl-phthalate; mono(3-carboxypropyl) phthalate (MCPP), metabolite of di-nbutyl phthalate and di-n-octyl phthalate; monobenzyl phthalate (MBzP), metabolite of butylbenzyl phthalate (BBzP); and mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP) and mono(2-ethyl-5-carboxypentyl) phthalate (MECPP), metabolites of di(2-ethylhexyl) phthalate. Specific gravity (SG) of urine samples were measured using a handheld digital refractometer (ATAGO Company Ltd., Tokyo, Japan) and metabolite concentrations in utero EDC exposures and BMI trajectories | 551 below the limit of quantitation (LOQ) were assigned a value of LOQ/sqrt (2) .
Individual metabolites were then corrected for SG which takes urinary dilution into account, using:
, where P c is the SGcorrected BPA or phthalates metabolite concentration (ng/mL), P is the measured urinary BPA or phthalates metabolite concentration, SG i is the urinary specific gravity for the individual and SG p is the median of the urinary specific gravities for the sample (SG p for mothers = 1.013) (17).
Covariates
At 1 month postpartum, maternal weight and height were measured to the nearest 0.1 kg and 0.1 cm, respectively (BAME Mod 420; Catálogo Médico). Sociodemographic characteristics of the mother were collected at the third trimester through questionnaires administered by study personnel. Socioeconomic status was represented by the years of completed schooling by the mother at enrollment.
Statistical analysis
Data analysis was completed using SAS (version 9.3; SAS Institute, Cary, NC, USA). SG-corrected metabolites were natural log-transformed to normality prior to analyses. Each child had 5 to 12 observations for BMI; values were checked for biological implausibility by visually assessing their growth trajectory; values such as decreases in height were removed (n = 6 observations).
We fit sex-stratified models to assess the differences in predicted BMI trajectories associated with exposure to tertiles of BPA and phthalates metabolites. Following an approach similar to published methods (18), we fit mixed effects models with fixed effects using a fractional polynomial age approach to model BMI trajectory (19) . First, the optimal fractional age polynomials to model the
were selected where m is the model degree and the exponential p j was selected from a set of eight chosen values which included À2, À1, À0.5, log, 0.5, 1, 2 and 3. The fewest number of terms in the model degree was set at m = 3 and the maximum degree was set to m = 8. Therefore, 219 candidate models were considered, with 1 model of the 8th degree, 8 models of the 7th degree, etc. and 56 models of the 3rd degree. The optimal number of age terms were selected separately for male and female children based on smallest Akaike information criterion (AIC) and Bayesian information criterion (BIC). All models contained random intercept and linear age to account for within-child correlation in the measures. Models for each sex are shown in Supplementary  Table 1 . Second, for BPA and the nine phthalates metabolites, tertiles of the metabolites and their interaction terms with the selected age variables were entered as fixed effects. Likelihood ratio tests were conducted with the null model containing the age polynomials and the a priori identified covariates mother's years of schooling and BMI at 1 month postpartum centered at their means, against the fully adjusted model additionally containing the SG-corrected metabolites and their interaction terms with the age polynomials. Estimated model coefficients from fully adjusted models were used to obtain predicted BMI trajectories for ages 0.25 to 13.8 years for each tertile of exposure when P< 0.05 from the likelihood ratio test. These plots demonstrate the estimated BMI trajectories for each tertile of the phthalates metabolite or BPA exposure for an individual with otherwise average characteristics.
Results
Among 249 children, 47% were boys ( Table 1 ). The average follow-up for children was 10.3 years. Among 2162 total visits, 78% occurred at or before 5 years of age. Distributions of BPA and phthalates metabolites in maternal third trimester urine show detectable concentrations in most pregnancy samples with no differences by sex (Supplementary Table 2 ).
We constructed BMI trajectories for models that showed a better fit with the inclusion of the BPA or phthalates metabolite (Supplementary Table 3 ). In boys, the likelihood ratio tests showed a better fit for models including the phthalates metabolites MiBP, MBzP, MEHP and MEHHP. In girls, model fit was best with the inclusion of MECPP. We did not find a relationship between BPA exposure and BMI trajectories.
Trajectories for each tertile of metabolite exposure crossed at various times during the modelled ages, particularly in the first few years. Some BMI trajectories which appeared to be stable at the highest trajectory, such as the second tertile of exposure to MiBP in boys, did not remain so after the age of 5 years (Fig. 1) . Conversely, while exposure to the highest tertile of MEHP in infancy predicted the highest BMI trajectory in boys, after 2 years of age the highest trajectory was predicted by exposure to the second tertile of MEHP exposure. Confidence intervals widened as ages increased due to fewer observations. For the modelled trajectories in boys, the first and second tertiles of exposure had the highest predicted BMI trajectory. Exposure to the first tertile of MiBP and MBzP predicted the lowest BMI trajectory in early childhood but crossed over to predict the highest BMI by age 14. With the phthalates metabolites MEHP and MEHHP, the second tertile of exposure was consistently predictive of the highest BMI trajectory from early childhood on. In girls, modelling showed that the third tertile of MECPP predicted the highest BMI trajectory by age 14, although prior to age 9 the highest level of exposure predicted the lowest BMI trajectory (Fig. 2) . 
Discussion
In this prospective study modelling BMI trajectories, we observed that in utero exposure to phthalates metabolites differentially influenced the BMI trajectories of boys and girls. While tertile trajectories crossed frequently in early childhood, by age 14, we found that different tertiles of exposure predicted the highest attained BMI. This was observed with the highest tertile of exposure in girls but the first or second tertile of exposure in boys. We did not detect any significant association with BPA. Some previous studies have found positive associations between BPA and phthalates metabolites with child BMI; most longitudinal studies have outcomes in early childhood with few occurring in late childhood and early adolescence (11, 12, (20) (21) (22) (23) . Results from these longitudinal studies have been mixed, with differences reported by metabolites, sex, and age. The mixed findings from prenatal exposures and child BMI outcomes may be due to the different ages that child outcomes are measured, which may be influenced by the timing of puberty or adiposity rebound. Therefore, we explored the use of growth trajectories as an alternate method of assessing the potential impact of early life exposures. The fluctuating trajectories indicated that the age outcomes are assessed at can influence the interpretation of the relationship between levels of exposures with child outcome. This is likely a contributing reason why some metabolites are positively associated with child BMI at one age but not another. This is illustrated by contrasting the results we obtained here with previous work by others. Deierlein et al. (10) observed higher BMI for girls aged 7-13 years when they were exposed at 6-8 years to medium vs. low concentrations of MBzP while, in previous work, we found a negative relationship between prenatal MBzP exposure and child's BMI at ages 8-14 years with no modification by sex (10, 12) . However, we only observed a relationship with MBzP among boys in this study. Similarly, a pooled analysis of three prospective cohorts in the USA showed sexually dimorphic associations with high molecular weight phthalates metabolites (MEHP, MEHHP, MEOHP and MECPP) negatively associated with BMI in girls, but no associations with boys (24) . In previous work, we found urinary concentrations of MEHP in boys were negatively associated with child adiposity but did not find a relationship among girls (12) . This was inconsistent with other studies which observed MEHP to be inversely associated with BMI in girls both cross-sectionally and longitudinally (9, 10) . Using BMI trajectory modelling to reassess our findings of MEHP exposure in utero, we found a relationship among boys but not girls. These differences in results may potentially be due to the close trajectory paths and overlapping confidence intervals. However, with further refinement, growth trajectory modelling could be a useful tool to assess how exposures may alter trajectories of growth in children and may aid in interpreting how different levels of exposures may result in different associations.
The observed sex differences are thought to be due to the endocrine-disrupting mechanisms of phthalates metabolites. Phthalates are antiandrogenic and are able to influence energy homeostasis through increasing the number of adipocytes, as well as increasing lipid accumulation; their action is not through direct interaction with the androgen Figure 2 Female body mass index (BMI) trajectory for teritles of pregnancy MECPP, mono(2-ethyl-5-carboxypentyl) phthalate exposure.
receptors but through stimulation of the peroxisome proliferator-activated receptors (PPARs) family of nuclear receptors (8, 25) . PPARα in particular has been found to have sex-differential effects, with exposure to MEHP significantly increasing body weight and fat pads of male but not female mice (26) .
Limitations of this study include the relatively small sample size and fewer number of observations of BMI measures after the age of 5, as follow-up was not systematic after that point in time. Children had 1-3 measurements after that age and a few (n = 21) had only 1 measurement after the age of 5. This modelling is exploratory in examining whether growth trajectories could be constructed using available data. Restricting growth modelling to observations before the age of 5 would have altered reported results and any further work will need to ensure greater data support for more precise modelling. Our interpretations should therefore be viewed with caution until further studies are conducted with more observations. We also chose to use fractional age polynomials rather than splines to model growth trajectories; spline models are more flexible but require predefined decisions on the number and placement of age knots as well as requiring continuous data support. However, we wanted to explore how growth curves would form based on the data and much of our data on BMI was collected before the age of 5.
Another limitation was the use of a single spot urine in pregnancy for analyses of metabolites. Concentrations of metabolites are known to have short metabolic half-lives, with <24 h for phthalates metabolites and <5-6 h for BPA, and exhibit temporal variability; a single spot measure may therefore not be capable of accurately assessing individuals (27, 28) . However, individuals tend to exhibit consistent behaviors that would result in more consistent exposures, which have been shown by other studies (29) . Our geometric mean (GM) urinary concentrations of metabolites were comparable or lower compared with those reported by others in the pregnancy period. In a Californian population, Harley et al. (11) reported a GM of 1.1 ng/mL for BPA averaged across 2 pregnancy time points, which was higher than our 0.7 ng/mL and 0.9 ng/mL for boys and girls, respectively. Similarly, higher values were reported by Vafeiadi et al. (12) among a Greek population during the first trimester of pregnancy (1.2 ng/mL). For phthalates metabolites, higher GM values were reported by Buckley et al. 137.8; MiBP: 7.3; MBzP: 7.0; MCPP: 2.1). While prenatal exposure to BPA was positively associated with BMI z-score in boys, but negatively in girls, at 4 years of age in the Rhea cohort (21), we did not find any differences in BMI trajectories by levels of BPA exposure, which may be due to the high proportion of values measured <LOQ. It is also possible that trimester-specific associations may reveal vulnerable windows for in utero exposures, but there are too few studies with trimester-specific exposures to draw any conclusions. Additionally, we also chose to correct for SG, rather than creatinine, when controlling for urinary dilution as creatinine is influenced by factors such as age, sex, and muscle mass (31) .
Exposures to BPA and phthalates metabolites are influenced by a variety of factors such as diet, physical activity, and use of personal care products. We did not include dietary intakes, consumer product use, or physical activity as potential confounders, which will impact the amount of residual confounding. We also relied on maternal BMI collected at 1 month postpartum rather than prepregnancy BMI because of limited availability of self-reported heights and weights of the mothers at recruitment into the original birth cohorts.
However, strengths of our study include the extensive follow-up within this prospective study design, allowing the construction of growth trajectories. Unlike cross-sectional studies, where there is possibility of reverse causality from higher urinary metabolites in heavier individuals due to increased dietary intake or volume of consumer product use, longitudinal studies provide a temporal sequence of events and we were able to measure exposures in utero during a critical time of development. Additionally, the construction of BMI trajectories based on exposure in pregnancy is a novel method of assessing the potential impacts that these metabolites could have on child growth on a continuous scale, rather than exploring these associations at various ages.
Conclusion
We found different levels of exposure to phthalates metabolites were associated with child growth by sex. In girls, the highest level of exposure to MECPP was associated with the highest predicted BMI by age 14, while lower levels of exposure to MiBP, MBzP, MEHP, and MEHHP were associated with the highest predicted BMI in boys. Our findings suggest that timing of outcome measurement may influence associations observed. Further follow-up in this study will provide us with anthropometric measures to capture in utero EDC exposures and BMI trajectories | 555 trajectories through adolescence. Other studies are needed and should consider more evenly distributed measurements and confounding variables for growth modelling. Trajectory modelling is a potential method to better understand how exposures to endocrinedisrupting compounds may influence growth.
